Montana seeks to make the US state act as a PBM

22 March 2001

US Representative Brad Newman has introduced a bill in the Montana statelegislature that would have the state act as a pharmacy benefit manager for around 220,000 Montanans who cannot afford health insurance or who carry insufficient policies.

Drugmakers would be required to give the state upfront discounts for volume purchases, similar to those which some firms now offer on drugs bought through Medicaid, reports the Associated Press. The program's cost would be about $16 million over the next two years, mostly going for staff and equipment.

Rep Newman told the Montana House Appropriations Committee that the drug industry is the most profitable in the world, so it is unfair that so many Montanans cannot afford the prescriptions they need, said the AP. The Pharmaceutical Research and Manufacturers of America compared the plan to Maine's proposed Act to Establish Fairer Prescription Drug Prices (Marketletter March 12), saying it is unconstitutional and would violate interstate commerce laws by changing the prices of drugs in one state but not others.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight